REperfusion With P2Y12 Inhibitors in Addition to mEchanical thRombectomy for perFUsion Imaging Selected Acute Stroke patiEnts

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(13 sites)

France

CHU de Besançon, Besançon

Hôpital Pellegrin (CHU de Bordeaux), Bordeaux

Hospices civils de Lyon, Hôpital Pierre Wertheimer, Bron

Hôpital Salengro (CHU Lille), Lille

Hôpital Dupuytren (CHU Limoges), Limoges

CHU La Timone, Marseille

Hôpital Central (CHU de Nancy), Nancy

Hôpital Lariboisière AP-HP, Paris

Hôpital Pitié-Salpêtrière AP-HP, Paris

Hôpital Fondation A de Rothschild, Paris

CHU de Strasbourg, Strasbourg

Hôpital Foch, Suresnes

Hôpital Purpan (CHU de Toulouse), Toulouse